Megan Smeykal - 01 Jan 2022 Form 3 Insider Report for TELA Bio, Inc. (TELA)

Role: Chief Accounting Officer, Controller
Signature: /s/ Megan Smeykal
Issuer symbol: TELA
Transactions as of: 01 Jan 2022
Net transactions value: $0
Form type: 3
Filing time: 07 Jan 2022, 15:24:56 UTC
Next filing: 25 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TELA	Common Stock						7,717	01 Jan 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	TELA	Stock Option (Right to Buy)							01 Jan 2022	Common Stock	7,500	$11.62	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Common stock consists of 6,375 restricted stock units and 1,342 restricted stock units that will vest in four equal annual installments beginning on February 24, 2022 and March 31, 2022, respectively, each subject to the Reporting Person's continued service through the applicable vesting dates.
F2	The option vested 25% on December 13, 2020, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.